Invokana Lawsuit Plaintiff Alleges Drug Caused DKA Side Effect

May 15, 2016 – – TheProductLawyers.com reports on side effects encompassing potential medical issues including degradation of the body’s cardiovascular, renal and blood systems which have been linked to diabetes drug Invokana. The U.S. Food and Drug Administration (FDA) approved the use of Invokana in 2013. Since that time, there have been lawsuits filed related to the use of this SGLT2 inhibitor drug, and the potential adverse impacts on patients taking the drug. There are numerous SGLT2 inhibitor drugs on the market. However, Invokana seems to have garnered the most attention in the media and among medical professionals.

One lawsuit filed in December 2015 against Janssen Pharmaceuticals, a subsidiary of Johnson and Johnson, in the Southern District of Alabama alleges that the plaintiff using Invokana was not made aware of the possible side effects that could ensue from using the drug and was negligent in not better educating the public and medical professional of the potentially dangerous side effects. The plaintiff contends that she developed diabetic ketoacidosis just a very short time after starting treatment with Invokana. Ketoacidosis is a life-threatening condition characterized by an abnormally high level of toxic acid in the blood and can often times result in diabetic coma or death if not treated immediately.

She also alleges kidney problems resulted from her taking Invokana since the drug places an extra burden on the kidneys, as it works to maintain blood sugar (glucose) levels by removing extra sugar from the body via urination. Anyone have pre-existing kidney issues should be keenly aware of the potential adverse impact on the organ.

The plaintiff further contends in her lawsuit that she was given Invokana as a treatment for her type-1 diabetes, which is an “off-label” use of the drug. Invokana was only FDA approved for the treatment of type-2 diabetes but nevertheless, was promoted by Janssen as a treatment for type-1 as well, a marketing move perceived by many as being “controversial.”

For more information about the Invokana lawsuits, or this press release, please contact TheProductLawyers.com on 888-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60009958